foxo4 dri peptide senolytic 2023 2024 FOXO4-DRI FOXO4/p53 – Peptagon Frontiers | Senolytic Peptide FOXO4-DRI
Frontiers Senolytic Peptide FOXO4 DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Computational design of peptide targeting FOXO4. a, Domains of FOXO4 Download Scientific Diagram FOXO4 DRI Peptide 10 mg Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway
Pay in 4 interest-free payments of $5.07 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




